Conclusion: Allogeneic MSCs administration has initially improved symptoms, quality of life, exercise tolerance and reduced exacerbations in COPD patients with C and D groups. Keywords: Allogeneic umbilical cord derived mesenchymal stem cells, chronic obstructive pulmonary disease.